Placental aryl hydrocarbon hydroxylase activity and placental calcifications. 1992

G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
Epidemiological Research Unit, French National Institute of Health and Medical Research, INSERM.

Induction of aryl hydrocarbon hydroxylase (AHH) activity in the placenta as a result of maternal exposure to polycyclic aromatic hydrocarbons contained in cigarette smoke has been well documented. Furthermore, calcifications are more prevalent in the placentas of pregnant smokers than in those of non-smokers. The present study examines whether this latter relationship could be explained by the induction of AHH activity in the placenta. AHH levels were determined at birth in 141 unselected pregnant women admitted for delivery. Macroscopic placental examination was performed for vascular lesions, abnormalities of placental shape, of the cord and parameters of placental maturity such as basal and parenchymatous calcifications. Significant increases in the prevalence of calcifications of the placental basal plates and parenchyma with the induction of placental AHH were found. A similar significant association between smoking and AHH activation was also observed. These findings remained unchanged when controlling for smoking status assessed both by questionnaire and presence of cotinine in mother's urine. Moreover, the apparent association between smoking 'factor' and calcifications disappeared when controlling for AHH induction. Therefore, the association between smoking and placental calcifications previously related could be mediated by the AHH induction.

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D003367 Cotinine The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties. Scotine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits

Related Publications

G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
January 1983, Placenta,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
June 1983, Biochemical pharmacology,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
October 1973, Toxicology and applied pharmacology,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
March 1981, The British journal of dermatology,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
January 1979, Cancer biochemistry biophysics,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
April 1975, Journal of the National Cancer Institute,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
August 1981, British journal of clinical pharmacology,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
January 1986, Journal of dental research,
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
February 1979, Lancet (London, England),
G Huel, and F Girard, and C Nessmann, and J Godin, and P Blot, and G Bréart, and T Moreau
September 1983, British journal of clinical pharmacology,
Copied contents to your clipboard!